| Q90266290 | 12-year changes in cardiovascular risk factors in people with major depressive or bipolar disorder: a prospective cohort analysis in Germany |
| Q34035818 | A Long Time Coming - The Creation of an Evidence Base for Physical Activity Prescription to Improve Health Outcomes in Bipolar Disorder |
| Q42751743 | A brief motivational intervention for preventing medication-associated weight gain among youth with bipolar disorder: treatment development and case report |
| Q38559876 | A combined analysis of worldwide studies demonstrates an association between bipolar disorder and tobacco smoking behaviors in adults |
| Q36043355 | A composite peripheral blood gene expression measure as a potential diagnostic biomarker in bipolar disorder |
| Q36217653 | A report on older-age bipolar disorder from the International Society for Bipolar Disorders Task Force |
| Q48641811 | Advances in bipolar disorder: selected sessions from the 2011 International Conference on Bipolar Disorder |
| Q64069466 | Adverse stroke outcomes among patients with bipolar disorder |
| Q35502460 | Antipsychotic drugs and risks of myocardial infarction: a self-controlled case series study |
| Q38524175 | Association between history of psychosis and cardiovascular disease in bipolar disorder |
| Q33717601 | Association of obesity and treated hypertension and diabetes with cognitive ability in bipolar disorder and schizophrenia |
| Q47194159 | Bipolar disorder and related mood states are not associated with endothelial function of small arteries in adults without heart disease |
| Q44561014 | Bipolar disorder in a national survey using the World Mental Health Version of the Composite International Diagnostic Interview: the impact of differing diagnostic algorithms |
| Q48191720 | Bipolar disorder in women |
| Q35277878 | Body mass, cardiovascular risk and metabolic characteristics of young persons presenting for mental healthcare in Sydney, Australia |
| Q44142664 | Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. |
| Q47659434 | Cardiometabolic effects of psychotropic medications. |
| Q36810120 | Cardiovascular mortality in bipolar disorder: a population-based cohort study in Sweden |
| Q49611619 | Cardiovascular risk and bipolar disorder: factors associated with a positive coronary calcium score in patients with bipolar disorder type 1. |
| Q43792304 | Cardiovascular risk factors in outpatients with bipolar disorder: a report from the Brazilian Research Network in Bipolar Disorder |
| Q35739915 | Cerebral White Matter Lesions and Affective Episodes Correlate in Male Individuals with Bipolar Disorder |
| Q37095303 | Cigarette smoking and impulsivity in bipolar disorder |
| Q38019745 | Combining redox-proteomics and epigenomics to explain the involvement of oxidative stress in psychiatric disorders |
| Q38259465 | Current state of biomarkers in bipolar disorder |
| Q52599080 | Depressive Symptoms, Antidepressant Use, and Hypertension in Young Adulthood. |
| Q37349876 | Effects of acute aerobic exercise on neural correlates of attention and inhibition in adolescents with bipolar disorder. |
| Q61807187 | Elevated Familial Cardiovascular Burden Among Adolescents With Familial Bipolar Disorder |
| Q64078200 | Evaluation of Endothelial Dysfunction in Bipolar Affective Disorders: Serum Endocan and Urotensin-II Levels |
| Q47915978 | Eveningness and Its Associated Impairments in Remitted Bipolar Disorder |
| Q33811283 | Evidence for somatic gene conversion and deletion in bipolar disorder, Crohn's disease, coronary artery disease, hypertension, rheumatoid arthritis, type-1 diabetes, and type-2 diabetes |
| Q45350830 | Expression of matrix metalloproteinases in patients with bipolar disorder |
| Q53420692 | Further Evidence of Accelerated Aging in Bipolar Disorder: Focus on GDF-15. |
| Q37213547 | General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial. |
| Q36082076 | Hypertension in postmenopausal women |
| Q36291638 | Increased breakdown of kynurenine towards its neurotoxic branch in bipolar disorder |
| Q37896630 | Insulin dysfunction and allostatic load in bipolar disorder |
| Q36593028 | Integrating Primary Care and Behavioral Health: A Nurse Practitioner's Perspective |
| Q39305705 | Is Mania the Hypertension of the Mood? Discussion of A Hypothesis |
| Q34515834 | LURASIDONE IN THE LONG-TERM TREATMENT OF PATIENTS WITH BIPOLAR DISORDER: A 24-WEEK OPEN-LABEL EXTENSION STUDY |
| Q60633611 | Les anomalies du sommeil peuvent-elles participer au risque cardio-vasculaire des troubles bipolaires ? |
| Q37254536 | Leveraging electronic health records to study pleiotropic effects on bipolar disorder and medical comorbidities. |
| Q41325445 | Lipid peroxidation biomarkers in adolescents with or at high-risk for bipolar disorder. |
| Q37008781 | Long-term risk of myocardial infarction and stroke in bipolar I disorder: A population-based Cohort Study |
| Q39161509 | Medical Co-morbidities Among Patients with Severe Mental Illnesses in a Community Health Facility in Nigeria |
| Q50627364 | Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE). |
| Q40317424 | Metabolic Syndrome and Bipolar Affective Disorder: A Review of the Literature |
| Q37327349 | Monotherapy With Major Antihypertensive Drug Classes and Risk of Hospital Admissions for Mood Disorders |
| Q97425661 | Nitrous oxide as a putative novel dual-mechanism treatment for bipolar depression: Proof-of-concept study design and methodology |
| Q38416496 | Non-invasive vascular imaging is associated with cardiovascular risk factors among adolescents with bipolar disorder |
| Q36751327 | Obesity and the three-year longitudinal course of bipolar disorder |
| Q37960632 | Oral ziprasidone in the treatment of patients with bipolar disorders: a critical review |
| Q60020537 | Oxidatively-induced DNA damage and base excision repair in euthymic patients with bipolar disorder |
| Q58580344 | Patient Participation in the Development of a Customized M-Health Intervention to Improve Medication Adherence in Poorly Adherent Individuals with Bipolar Disorder (BD) and Hypertension (HTN) |
| Q45193773 | Personality and cardiovascular risk: association between hypertension and affective temperaments-a cross-sectional observational study in primary care settings |
| Q38546598 | Pharmaceuticals that contain polycyclic hydrocarbon scaffolds. |
| Q83918293 | Postmenopausal hypertension |
| Q35496330 | Preliminary findings regarding proinflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disorders |
| Q36078546 | Presence of an interaction between smoking and being overweight increases risks of hypertension, diabetes, and cardiovascular disease in outpatients with mood disorders |
| Q37505046 | Prevalence and correlates of heavy smoking and nicotine dependence in adolescents with bipolar and cannabis use disorders |
| Q37265487 | Prevalence, clinical presentation and differential diagnosis of pediatric bipolar disorder |
| Q38151984 | Primary prevention of cardiovascular events in patients with major mental illness: a possible role for statins |
| Q46197184 | Reasons for Nonadherence to Psychiatric Medication and Cardiovascular Risk Factors Treatment Among Latino Bipolar Disorder Patients Living in Puerto Rico: A Qualitative Study. |
| Q55427645 | Recent Findings in the Genetics of Blood Pressure: How to Apply in Practice or Is a Moonshot Required? |
| Q26849474 | Review of the evidence: prevalence of medical conditions in the United States population with serious mental illness |
| Q37255608 | Risk of myocardial infarction and stroke in bipolar disorder: a systematic review and exploratory meta-analysis. |
| Q36728737 | Sleep duration is associated with dyslipidemia in patients with bipolar disorder in clinical remission |
| Q52690038 | Social stress response in adolescents with bipolar disorder. |
| Q44522561 | Specific subcellular changes in oxidative stress in prefrontal cortex from patients with bipolar disorder |
| Q26749044 | Strategies and methods to study female-specific cardiovascular health and disease: a guide for clinical scientists |
| Q37863532 | Surgical treatment of morbid obesity among patients with bipolar disorder: a research agenda |
| Q36200016 | The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings |
| Q26862278 | The Potential Role of the NLRP3 Inflammasome as a Link between Mitochondrial Complex I Dysfunction and Inflammation in Bipolar Disorder |
| Q35629735 | The association between antipsychotic agents and the risk of myocardial infarction: a systematic review |
| Q35167517 | The burden of obesity among adults with bipolar disorder in the United States |
| Q38003199 | The clinical management of bipolar disorder complexity using a stratified model |
| Q37059617 | The co-occurrence of cigarette smoking and bipolar disorder: phenomenology and treatment considerations |
| Q38085460 | The neurobiology of bipolar disorder: identifying targets for specific agents and synergies for combination treatment |
| Q35844284 | The relationship between subtypes of depression and cardiovascular disease: a systematic review of biological models |
| Q37588877 | Toward clinically applicable biomarkers in bipolar disorder: focus on BDNF, inflammatory markers, and endothelial function |
| Q38269372 | Treatment of bipolar depression: making sensible decisions |
| Q50866263 | Using the Brief Assessment of Cognition in Schizophrenia (BACS) to assess cognitive impairment in older patients with schizophrenia and bipolar disorder. |
| Q35754658 | Vascular function is not impaired early in the course of bipolar disorder |
| Q64066862 | Why are somatic diseases in bipolar disorder insufficiently treated? |